Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

Abstract Background The relapse rate in early stage non-small cell lung cancer (NSCLC) after surgical resection is high. Prognostic biomarkers may help identify patients who may benefit from additional therapy. The Helicase-like Transcription Factor (HLTF) is a tumor suppressor, altered in cancer ei...

Full description

Bibliographic Details
Main Authors: Ludovic Dhont, Melania Pintilie, Ethan Kaufman, Roya Navab, Shirley Tam, Arsène Burny, Frances Shepherd, Alexandra Belayew, Ming-Sound Tsao, Céline Mascaux
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Cancer
Subjects:
Non-small cell lung cancer
HLTF
Prognosis
Alternative splicing
Online Access:http://link.springer.com/article/10.1186/s12885-018-4215-y

Internet

http://link.springer.com/article/10.1186/s12885-018-4215-y

Similar Items